Discuss the cellular, genetic, and molecular changes that characterise malignancy and explain how these, manifest in the hallmarks of cancer cells. (from 6039BMS) Critically evaluate the diagnosis, treatment and monitoring

Assignment Task

As this is a resit assessment you are required to make a substantive improvement based on the feedback left on the previous submission.

This assessment requires you to interpret data presented to you (in a case study) to identify a haematological malignancy. You are then required to research this subject area with specific reference to the areas identified in the details section of this brief. The requirement to independently gather information, interpret and analyse relevant data, and communicate this in an appropriate style, combines several skills developed throughout your course and it is reflection of the type of tasks that would be encountered in science-based careers and postgraduate study.

You will be presented with multiple sets of laboratory data, each of which aligns to a particular haematological malignancy. 

You will be required to select ONE set of data and identify the suspected malignancy from the data presented. 

You then need to prepare an informative resource (such as a poster, leaflet, or web/electronic resource) to communicate information on the selected malignancy to ONE of the following audiences:

• Health professional
• Scientific professional
• Service user

Whichever format is chosen, you need to include the following sections/subheadings:

• Development and characteristics of the malignancy 
  • In this section you must identify the malignancy and define key markers/characteristics involved. You are expected to discuss cellular and genetic changes within the cells.
• Physiological consequences
  • You must report how the development of the malignancy leads to physical symptoms.
• Diagnostic methods & therapeutic options
  • You must interpret and evaluate the laboratory data provided from patient-based students used in the diagnosis, treatment, and monitoring of the malignancy. To do this effectively, you must evaluate data from published literature which supports aspects of the diagnostic, therapeutic or monitoring options of the malignancy. 

The style and language included in the resource you produce must be appropriate for the audience you have selected. You must use Microsoft Sway, Microsoft PowerPoint or Adobe Express to produce your resource as this will allow your work to be readily accessed. Use of other types of software may mean that your work cannot be viewed and thus cannot be marked/or feedback provided.

The resource must not include voiceovers or narration, these will not be considered when marking the content of the work.

You MUST utilize appropriate research publications and their data/findings to illustrate current research on your chosen topic.

All resources MUST be referenced using the APA 7.0 Referencing Style as expected of a scientific article. For more support and advice on how to reference appropriately please see the online referencing guidance or contact your Academic Liaison Librarian.

Module Learning Outcomes:

The Learning Outcomes for this module align to the marking criteria which can be found at the end of this brief. Ensure you understand the marking criteria to ensure successful achievement of the assessment task. The following module learning outcomes are assessed in this task:

This assessment is designed to assess Learning Outcomes 1-4 of the module:

1. Discuss the cellular, genetic, and molecular changes that characterise malignancy and explain how these, manifest in the hallmarks of cancer cells. (from 6039BMS)
2. Critically evaluate the diagnosis, treatment and monitoring of haematological malignancy taking a multidisciplinary approach (from 6040BMS).
3. Explain, interpret, and critically evaluate laboratory data in patient-based case studies and other problem-based scenarios in haematological malignancy.
4. Communicate information succinctly and clearly in an appropriate format to chosen audience (health or scientific professional or service user).